{"id":"https://openalex.org/W2394856955","doi":"https://doi.org/10.1158/1535-7163.targ-15-pl08-03","title":"Abstract PL08-03: Ovarian PDX models: Of Mice and (Wo)men\u2026and personalized treatment","display_name":"Abstract PL08-03: Ovarian PDX models: Of Mice and (Wo)men\u2026and personalized treatment","publication_year":2015,"publication_date":"2015-12-01","ids":{"openalex":"https://openalex.org/W2394856955","doi":"https://doi.org/10.1158/1535-7163.targ-15-pl08-03","mag":"2394856955"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-15-pl08-03","doi":"https://doi.org/10.1158/1535-7163.targ-15-pl08-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-15-pl08-03","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089153267","display_name":"Paul Haluska","orcid":"https://orcid.org/0000-0003-3283-4512","observed_orcids":["https://orcid.org/0000-0003-3283-4512"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paul Haluska","raw_affiliation_strings":["Merck Research Laboratories, Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089153267"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"12_Supplement_2","first_page":"PL08","last_page":"03"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9959999918937683},{"id":"https://openalex.org/keywords/platinum-resistance","display_name":"platinum resistance","score":0.5509999990463257},{"id":"https://openalex.org/keywords/chemotherapy-response-prediction","display_name":"chemotherapy response prediction","score":0.8159999847412109},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.6629999876022339},{"id":"https://openalex.org/keywords/hrd-score","display_name":"HRD score","score":0.7059999704360962},{"id":"https://openalex.org/keywords/niraparib","display_name":"niraparib","score":0.9589999914169312},{"id":"https://openalex.org/keywords/papp-a","display_name":"PAPP-A","score":0.7739999890327454},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6449999809265137},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.5789999961853027},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.7229999899864197},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.6129999756813049},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.5130000114440918},{"id":"https://openalex.org/keywords/nsg-mice","display_name":"NSG mice","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.8147461414337158},{"id":"https://openalex.org/C2781100745","wikidata":"https://www.wikidata.org/wiki/Q1977435","display_name":"Debulking","level":4,"score":0.8113429546356201},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7598088979721069},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.7051842212677002},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6426451206207275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5297093391418457},{"id":"https://openalex.org/C2780752271","wikidata":"https://www.wikidata.org/wiki/Q2637746","display_name":"Trabectedin","level":4,"score":0.4821012318134308},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.4613646864891052},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.44357994198799133},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4329664707183838},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4178239703178406},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2387354075908661},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.09817823767662048},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09728917479515076},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-15-pl08-03","doi":"https://doi.org/10.1158/1535-7163.targ-15-pl08-03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-15-pl08-03","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.75,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1882652474","https://openalex.org/W2085549282","https://openalex.org/W2099696346","https://openalex.org/W2006769811","https://openalex.org/W4400272595","https://openalex.org/W2592014838","https://openalex.org/W4414751585","https://openalex.org/W2285926565","https://openalex.org/W2566552668","https://openalex.org/W4392632013"],"abstract_inverted_index":{"Abstract":[0],"Ovarian":[1,296,452],"cancer":[2,88],"is":[3,39,47,308,376],"the":[4,40,81,96,112,132,139,151,158,170,221,224,231,251,292,295,320,339,361,428,433,465],"most":[5],"lethal":[6],"gynecological":[7],"malignancy.":[8],"Multiple":[9],"factors":[10],"contribute":[11],"to":[12,30,55,64,116,141,157,175,182,198,200,205,230,247,298,301,311,323,336,426,444],"this":[13,102],"poor":[14,28,90],"outcome,":[15],"including":[16,61,395],"late":[17],"stage":[18],"of":[19,22,43,83,101,203,223,253,271,294,343,418,432,464],"diagnosis,":[20],"propensity":[21],"recurrence":[23],"following":[24,32],"initial":[25,66],"remission,":[26],"and":[27,74,91,163,341,357,383,401,430,438,457,471],"responsiveness":[29,54,229,300],"chemotherapy":[31,67,302,325,390],"platinum-based":[33,183],"therapies.":[34],"Another":[35],"major":[36,195],"contributing":[37],"factor":[38],"heterogeneous":[41],"nature":[42,100],"ovarian":[44,87,143,225,314,332,344],"cancer,":[45],"which":[46],"indeed":[48],"multiple":[49],"tumor":[50],"type":[51],"with":[52,150,328],"varying":[53],"chemotherapy.":[56,184],"With":[57],"no":[58],"clear":[59],"biomarkers,":[60],"mutational":[62],"status":[63],"select":[65],"options,":[68],"treatment":[69,118],"decisions":[70],"are":[71,89,173,249,350],"often":[72],"empiric":[73],"not":[75,93,351],"individualized.":[76],"In":[77,359],"addition,":[78,360],"models":[79,172,192],"for":[80,365],"development":[82,340,417,429],"novel":[84,212,419],"therapies":[85],"in":[86,104,193,227,250,326,338,413],"do":[92],"typically":[94],"recapitulate":[95],"complex":[97],"or":[98,179],"individualized":[99,191],"disease":[103],"our":[105,321],"patients.":[106],"To":[107],"overcome":[108,445],"this,":[109],"we":[110,218,264],"initiated":[111],"Mayo":[113,133],"Avatar":[114,171],"Program":[115],"develop":[117],"nave,":[119],"orthotopic,":[120],"intraperitoneal,":[121],"patient-derived":[122],"xenografts":[123],"from":[124,277,316],"all":[125,194],"consenting":[126],"patients":[127,317,327],"undergoing":[128],"primary":[129],"debulking":[130],"at":[131,145],"Clinic.":[134],"We":[135,165,185],"have":[136,166,186,256,386,403],"now":[137,187,309],"demonstrated":[138,168,242,265,404],"ability":[140,293,322],"engraft":[142],"tumors":[144,154,161,440],"a":[146,257,278,304,377],"high":[147],"rate":[148],"(\u223c75%),":[149],"resultant":[152],"PDX":[153,345,366,453],"demonstrating":[155],"similarities":[156],"source":[159],"patient":[160],"histologically":[162],"molecularly.":[164],"also":[167],"that":[169,243,245,255,266,268],"able":[174],"accurately":[176],"predict":[177,299],"responsiveness,":[178],"lack":[180],"thereof,":[181],"generated":[188],"over":[189],"350":[190],"histological":[196],"subtypes":[197],"begin":[199,443],"understand":[201],"determinant":[202],"sensitivity":[204],"standard":[206],"cytotoxic":[207],"chemotherapy,":[208],"as":[209,211,372,380],"well":[210],"targeted":[213],"therapy.":[214],"Using":[215],"HRD":[216,258],"analysis,":[217],"previously":[219],"demonstated":[220],"usefulness":[222],"PDXs":[226,244,315],"predicting":[228],"PARP":[232],"inhibitor,":[233],"niraparib":[234,248],"(Haluska":[235],"et":[236,284],"al,":[237,285],"ENA,":[238],"2014).":[239],"This":[240,375],"work":[241],"respond":[246],"group":[252],"Avatars":[254,267,297],"score":[259],"greater":[260],"than":[261],"42.":[262],"Similarly,":[263],"had":[269],"expression":[270],"pregnancy-associated":[272],"plasma":[273],"protein-A":[274],"(PAPP-A),":[275],"benefitted":[276],"therapeutic":[279],"antibody":[280],"targeting":[281],"PAPP-A":[282],"(Becker":[283],"Mol":[286,482],"Cancer":[287,472,483],"Ther":[288,484],"2015).":[289],"Based":[290],"on":[291,389],"retrospectively,":[303],"prospective":[305],"clinical":[306],"trial":[307],"ongoing":[310],"determine":[312],"if":[313],"can":[318],"improve":[319],"individualize":[324],"recurrent,":[329],"platinum":[330],"resistant":[331],"cancer.":[333],"Challenges":[334],"continue":[335],"exist":[337],"use":[342],"modeling.":[346],"These":[347],"include,":[348],"but":[349,408],"limited":[352],"to,":[353],"protracted":[354],"engraftment":[355],"times":[356],"cost.":[358],"current":[362],"state-of-the":[363],"art":[364],"modeling":[367],"includes":[368],"immunosuppressed":[369,414],"hosts,":[370],"such":[371],"NSG":[373],"mice.":[374,415],"substantial":[378],"barrier,":[379],"both":[381],"innate":[382],"adaptive":[384],"immunity":[385],"an":[387],"impact":[388],"responsiveness.":[391],"Additionally,":[392],"immunotargeting":[393],"agents,":[394],"checkpoint":[396],"inhibitors,":[397],"cell-based":[398],"immunotherapy":[399],"strategies":[400],"vaccines,":[402],"promising":[405],"early":[406],"results,":[407],"cannot":[409],"be":[410],"optimally":[411],"studies":[412],"The":[416],"transgenic":[420],"mouse":[421],"strains":[422],"expressing":[423],"human":[424,435],"cytokines":[425],"support":[427],"maintenance":[431],"full":[434],"immune":[436],"repertoire":[437],"xenografted":[439],"will":[441],"hopeful":[442],"these":[446],"barriers.":[447],"Citation":[448],"Format:":[449],"Paul":[450],"Haluska.":[451],"models:":[454],"Of":[455],"Mice":[456],"(Wo)men\u2026and":[458],"personalized":[459],"treatment.":[460],"[abstract].":[461],"In:":[462],"Proceedings":[463],"AACR-NCI-EORTC":[466],"International":[467],"Conference:":[468],"Molecular":[469],"Targets":[470],"Therapeutics;":[473],"2015":[474],"Nov":[475],"5-9;":[476],"Boston,":[477],"MA.":[478],"Philadelphia":[479],"(PA):":[480],"AACR;":[481],"2015;14(12":[485],"Suppl":[486],"2):Abstract":[487],"nr":[488],"PL08-03.":[489]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-06-24T00:00:00"}